The first regional thoracic surgery centre will be established in Vietnam under a partnership between FV Hospital, a member of the Thomson Medical Group, and O2 Healthcare Group, a specialised lung centre in Singapore.
Vietnam posted 89 new COVID-19 infections cases, including one imported case, in the past six hours to 12pm on June 12, according to the Ministry of Health.
Da Nang Oncology Hospital and the UK's AstraZeneca Vietnam on March 12 signed an agreement to improve treatment capacity and the quality of medical care for lung cancer patients, targeting those in central Vietnam.
Cancer is the second leading cause of death in Vietnam, accounting for 17.9 percent and 19.9 percent of total deaths caused by diseases in the country in 2010 and 2017, respectively.
Raising tobacco taxes could help reduce smoking and the harm it causes to women and children, experts said at a workshop held in Hanoi early this week.
The Central Lung Hospital in Hanoi aims to utilise scientific and technological advances in lung cancer diagnosis and treatment, according to the hospital’s Director Prof. Dr. Nguyen Viet Nhung.
Many people know the environmental harm of using a traditional earthenware stove with coal, but due to its cheap price, many families still use it for cooking and warming their house, endangering their health, according to experts.
Vietnam’s national cancer control strategy needed to address the serious problem of infectious agents, which cause more than 20 percent of malignancies in the world, said Prof Nguyen Chan Hung, Chairman of the Vietnam Cancer Society.
The World Health Organization has revealed that tobacco kills more than seven million people each year, and 80 percent of them live in low-and middle-income countries.
Nearly 300 professors, doctors and leading oncologists have gathered in central Da Nang city to take part in a national conference on cancer prevention and control which opened on April 27.
The Da Nang’s Oncology Hospital, in cooperation with the biopharmaceutical firm AstraZeneca, has launched its first-ever Epidermal growth factor receptor (EGFR) mutation testing programme.
